Navigation Links
Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections
Date:12/19/2007

managed by a team of experienced entrepreneurs.

About aRigen Pharmaceuticals, Inc. (http://www.arigen.jp)

aRigen Pharmaceuticals, Inc. is a leading Japanese drug discovery and development company working on new molecular entities for infectious diseases. With a vision of "Discovered in Japan for Global Health" the company discovers pharmaceutical compounds in Japan in cooperation with leading Japanese life scientists, and develops them into innovative drugs for the global population. Several of its development programmes have already advanced to the clinical stage.

For further information please contact:

Axentis Pharma AG:

Leuholz 14, 8855 Wangen, Switzerland,

T +41-44-817-7817,

F +41-44-817-7818,

E board@axentispharma.com;

aRigen Pharmaceuticals, Inc.:

7-3-37/3F, Akasaka, Minato-ku, Tokyo 107-0052, Japan,

T +81-3-3470-3310,

F +81-3-3470-3345,

E bdd@arigen.jp;

Copy Editing & Distribution:

PR&D - Public Relations for Research & Development,

Michaela Fritsch,

Campus Vienna Biocenter 2, 1030 Vienna,

T +43-1-505-70-44,

E contact@prd.at.


'/>"/>
SOURCE Axentis Pharma AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
3. PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
6. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
7. Pharsight Achieves First License Sale for Public-Source Database
8. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
9. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
10. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Boston, MA (PRWEB) August 28, 2014 ... of wholesale construction materials, selected SoundConnect ... of their cloud based audio and web conferencing ... configured to support PrimeSource’s employees’ needs. SoundConnect ... technologies. , PrimeSource Building Products will be ...
(Date:8/27/2014)... 2014 Green & Grow Inc. (GGI) ... funding and secured Otter Capital as a significant new ... commercialization of GGI’s Agriplier™ technology, building on recent compelling ... “Since our first meeting, we have been impressed with ... space,” said Alan Sobba, President and CEO of GGI. ...
(Date:8/27/2014)... Aug. 27, 2014   MSC , a healthcare ... today announced the appointment of Mary Beth Loesch ... 28 years of experience preparing companies for rapid growth ... Executive Vice President of Corporate Development and Healthcare. In ... business , as well as corporate strategy and marketing. ...
(Date:8/27/2014)... -- Research and Markets  has announced the ... Polymer, Food & Beverage, Personal Care & Pharmaceutical) ... report to their offering. Lactic acid ... carbon atom. The main applications of lactic acid ... personal care product, and pharmaceutical industries. Lactic ...
Breaking Biology Technology:PrimeSource Chooses SoundConnect as Collaboration Provider 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3MSC names Mary Beth Loesch President and CEO 2Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2
... Health Care Forum discusses the future of Continuing ... ... Accredited online nursing courses,are replacing traditional classroom-based courses, offering nurses ... options., Ann Johnson, CEO of Wild Iris Medical Education took ...
... 2 Simbionix has announced the,release of a ... simulator that,gives trainees hands-on experience with different techniques ... tubal,sterilization and oophorectomy., The GYN module is ... developed for the LAP Mentor, the world,s most ...
... Japan and UNION CITY, Calif., June 2 ... that the two,companies have entered into a research ... and Asian development and,commercialization of sirolimus for the ... related macular degeneration (wet AMD) and,diabetic macular edema ...
Cached Biology Technology:Modernizing Continuing Education With Online Courses 2Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level 2Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions 2Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions 3
(Date:8/27/2014)... has shown that piglets can be weaned later with ... outcome of the study at the University,s Roseworthy campus, ... is an important finding for pig producers. It allows ... production. , "Sows don,t usually start their oestrous cycles ... piglets have been weaned," says Ms Alice Weaver, PhD ...
(Date:8/27/2014)... finds , Gamblers show the same tendencies as ... shown. , Researchers, led by Dr Elliot Ludvig of ... that found that both human gamblers and pigeons were ... rewards. , Published in Biology Letters , the ... role that memories of previous biggest wins and losses ...
(Date:8/26/2014)... Like a protective tent over a colony of ... infections especially difficult. Microorganisms protected in a biofilm ... antibiotic resistance and recalcitrance to treatment, and biofilm-protected ... bacterial infections in humans and are 50 to ... bacterial infections. , "In essence, we may have ...
Breaking Biology News(10 mins):Piglet weaning age no bar to litter frequency 2Gamblers are greedy bird-brains, University of Warwick research finds 2Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3
... MARC (Maximizing Access to Research Careers) Program has announced ... Conferences held in July, 2013. These awards are meant ... and scientists into the mainstream of the basic science ... at the FASEB Science Research Conferences. This year MARC ...
... MARC (Maximizing Access to Research Careers) Program has announced ... Study of Reproduction meeting in Montreal, Canada from July ... entry of students, postdoctorates and scientists from underrepresented groups ... to encourage the participation of young scientists at the ...
... 2011 and 2012, research from China,s Nanjing University made ... of genetic material from the plants they,d ingested could ... animals, own genes off. The surprising results from Chen-Yu ... one day be treated with medicinal food, but also ...
Cached Biology News:Hold the medicinal lettuce 2Hold the medicinal lettuce 3
Rat Antibody to Mouse TCR VB8.1,8.2:FITC Recognises the V beta 8.1 and V beta 8.2 determinants of the murine T cell receptor. Specificity: mouse TCR VB8.1 and 8.2...
fli-1...
Vesicle Associated Membrane Protein (VAMP 1/2)...
Anti-Mouse Valpha 2 TCR, Purified (Clone B20.1) (rat IgG2a)...
Biology Products: